In contrast, the MAPK/ERK/ET-1 pathway remains unchanged and is preferentially stimulated because of the compensatory hyperinsulinemia, leading to endothelial dysfunction (Figure 1) [34]. This evidence concerns the gene EDN1 and endothelial dysfunction.